<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20211214053413N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-06-24</date_registration>
      <primary_sponsor>University of Tehran</primary_sponsor>
      <public_title>Comparison of the effectiveness of cognitive-behavioral stress management technique (CBSMT) and self-care education and their combination in patients with type 2 diabetes</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the effectiveness of cognitive-behavioral stress management technique (CBSMT) and self-care education and their combination on treatment adherence, diabetic self-care, health status, perceived stress, lifestyle and quality of life in patients with type 2 diabetes</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-02-08</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/60830</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: In this research, randomization will be block, and the randomization unit will be cluster. Random assignment of patients (60 tons) to 4 groups (first 15 patients for group A, then 15 patients for group B, then 15 patients for group C and finally 15 patients for group D), using The order of generating integer random numbers (= INT (RAND (* * 60)) is performed by the rand function of Excel software. And D, will be done so that the names of the groups (intervention group 1; stress management based on cognitive-behavioral therapy, intervention group 2; self-care training, intervention group 3; stress management based on cognitive-behavioral therapy + self-care training, group Control; group 4) is written on four pieces of paper and will be folded, then by random selection of the first paper from four papers, type of intervention group A, by choosing the second paper from the remaining three papers, type of intervention group B, by selecting the third paper From the remaining two papers, the type of intervention in group C will be determined, and the remaining paper (fourth) will determine the type of intervention for group D.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Patients with type II diabetes.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group 1: Medication (Use of metformin according to the instructions of an endocrinologist) and 8 sessions of cognitive-behavioral stress management therapy (CBSMT) for 2 to 2.5 hours and once a week. Intervention 2: Intervention group 2: receive medication(Use of metformin according to the instructions of an endocrinologist)  and 8 sessions of self-care training for 2 to 2.5 hours and once a week. Intervention 3: Intervention group 3: Medication(Use of metformin according to the instructions of an endocrinologist)  and 8 sessions of combination of two treatments for 2 to 2.5 hours and once a week. Intervention 4: Control group: They only receive drug treatment(Use of metformin according to the instructions of an endocrinologist).</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All related data to participants are shared after hiding patient's name.

When:
The period of access to the present research data will be available 6 months after publication of the research results in the form of research articles.

To whom:
The present study data will be available only to researchers working in the academic and scientific institutions.

Conditions:
The output of statistical analysis will be available

Where to obtain:
Applicants can apply for documentation and data via email at jalaliamineh95@gmail.com

How to obtain:
After completion of the research and publication of the extracted articles, it will be available for a maximum 6 months later.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Amineh.Jalali</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Tehran - Enghelab Square - Enghelab St. - 16 Azar St. - Central Organization of the University of Tehran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1358879331</zip>
        <telephone>+98 34 4326 3329</telephone>
        <email>amineh.jalali@ut.ac.ir</email>
        <affiliation>University of Tehran</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Amineh Jalali</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Kerman. Houshang Moradi St. Kermani, Houshang Moradi 9 alley, Nikan building, second floor, unit 3</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1358879331</zip>
        <telephone>+98 34 4326 3329</telephone>
        <email>amineh.jalali@ut.ac.ir</email>
        <affiliation>University of Tehran</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age range 40-50 years
Having diabetes type 2 for at least six months with a specialist physician diagnosis
Higher education than the cycle
Not using other treatment psychotherapy programs and changing medications during the research</inclusion_criteria>
      <agemin>40 years</agemin>
      <agemax>50 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Have other types of diabetes
Have severe diabetic complications that prevent research
Acute or chronic medical illness that may cause problems with blood sampling</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>E08</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Diabetes mellitus due to underlying condition</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Diagnosis</i_code>
      <i_code>Diagnosis</i_code>
      <i_code>Diagnosis</i_code>
      <i_code>Diagnosis</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group 1: Medication (Use of metformin according to the instructions of an endocrinologist) and 8 sessions of cognitive-behavioral stress management therapy (CBSMT) for 2 to 2.5 hours and once a week.</i_keyword>
      <i_keyword>Intervention group 2: receive medication(Use of metformin according to the instructions of an endocrinologist)  and 8 sessions of self-care training for 2 to 2.5 hours and once a week.</i_keyword>
      <i_keyword>Intervention group 3: Medication(Use of metformin according to the instructions of an endocrinologist)  and 8 sessions of combination of two treatments for 2 to 2.5 hours and once a week.</i_keyword>
      <i_keyword>Control group: They only receive drug treatment(Use of metformin according to the instructions of an endocrinologist).</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Adherence therapy. Timepoint: Before an intervention, immediately after the intervention, 2 months after the end of intervention. Method of measurement: Madanlu Therapy Adherence Questionnaire (2013).</prim_outcome>
      <prim_outcome>Diabetic Self-Care. Timepoint: Before an intervention, immediately after the intervention, 2 months after the end of intervention. Method of measurement: Diabetes Self-Care Questionnaire.</prim_outcome>
      <prim_outcome>Health status. Timepoint: Before an intervention, immediately after the intervention, 2 months after the end of intervention. Method of measurement: Questionnaire Walker Health.</prim_outcome>
      <prim_outcome>Perceived Stress. Timepoint: Before an intervention, immediately after the intervention, 2 months after the end of intervention. Method of measurement: Cohen, Kamak and Marmerstein (1983) Perceived Stress Scale.</prim_outcome>
      <prim_outcome>Lifestyle. Timepoint: Before an intervention, immediately after the intervention, 2 months after the end of intervention. Method of measurement: Promoting Lifestyle Questionnaire (1983).</prim_outcome>
      <prim_outcome>Quality of life. Timepoint: Before an intervention, immediately after the intervention, 2 months after the end of intervention. Method of measurement: Quality of Life Questionnaire 36 questions.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Adherence of treatment. Timepoint: Before an intervention, immediately after the intervention, 2 months after the end of intervention. Method of measurement: Madanlu Therapy Adherence Questionnaire (2013).</sec_outcome>
      <sec_outcome>The amount of self-care. Timepoint: Before an intervention, immediately after the intervention, 2 months after the end of intervention. Method of measurement: Diabetes Self-Care Questionnaire.</sec_outcome>
      <sec_outcome>Health status. Timepoint: Before an intervention, immediately after the intervention, 2 months after the end of intervention. Method of measurement: World Health Organization Health Status.</sec_outcome>
      <sec_outcome>Lifestyle level. Timepoint: Before an intervention, immediately after the intervention, 2 months after the end of intervention. Method of measurement: Questionnaire Walker Health Promoting Lifestyle Questionnaire (1983).</sec_outcome>
      <sec_outcome>En Level of quality of life. Timepoint: Before an intervention, immediately after the intervention, 2months after the end of intervention. Method of measurement: Quality of Life Questionnaire 36 questions.</sec_outcome>
      <sec_outcome>Level of Perceived stress. Timepoint: Before an intervention, immediately after the intervention, 2 months after the end of intervention. Method of measurement: Cohen, Kamak and Marmerstein (1983) Perceived Stress Scale.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>University of Tehran</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-11-06</approval_date>
        <contact_name>Ethics Committee of the Faculty of Psychology and Educational Sciences, University of Tehran</contact_name>
        <contact_address>Tehran - Shahid Chamran Highway - Under Nasr Bridge (Gisha) Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
